Search research articles
Contact Us
Filters
Showing results (261-270 of 382) with videos related to
Page
of 39
Sort By:
Blood Cancer Journal
|
April 20, 2013
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma
L F Porrata, K M Ristow, T M Habermann, et al.
Leukemia
|
July 2, 2011
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study
G S Nowakowski, B LaPlant, T M Habermann, et al.
HGG Advances
|
January 20, 2022
An activating germline <i>IDH1</i> variant associated with a tumor entity characterized by unilateral and bilateral chondrosarcoma of the mastoid
Patrick R Blackburn, Jodi M Carter, Devin Oglesbee, et al.
JCO Oncology Practice
|
May 20, 2022
Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis
Christopher S Strouse, Melissa C Larson, Shawna L Ehlers, et al.
British Journal of Haematology
|
June 28, 2017
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy
Umar Farooq, Matthew J Maurer, Carrie A Thompson, et al.
Bone Marrow Transplantation
|
April 11, 2006
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia
M A Elliott, A Tefferi, W J Hogan, et al.
Mayo Clinic Proceedings
|
February 13, 2004
Therapeutic options in patients with lymphoma and severe liver dysfunction
Irene M Ghobrial, Robert C Wolf, Denise L Pereira, et al.
American Journal of Hematology
|
December 6, 2018
Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018
Alessia Castellino, Jose S Pulido, Patrick B Johnston, et al.
Transplantation and Cellular Therapy
|
June 25, 2022
Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell Lymphoma
Aung M Tun, Seth Maliske, Yucai Wang, et al.
Transplantation and Cellular Therapy
|
July 12, 2024
Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy
Aung M Tun, Yucai Wang, Seth Maliske, et al.
Page
of 39
Search research articles
Search
Showing results (261-270 of 382) with videos related to
Sort By:
Page
of 39
Blood Cancer Journal
|
April 20, 2013
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma
L F Porrata, K M Ristow, T M Habermann, et al.
Leukemia
|
July 2, 2011
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study
G S Nowakowski, B LaPlant, T M Habermann, et al.
HGG Advances
|
January 20, 2022
An activating germline <i>IDH1</i> variant associated with a tumor entity characterized by unilateral and bilateral chondrosarcoma of the mastoid
Patrick R Blackburn, Jodi M Carter, Devin Oglesbee, et al.
JCO Oncology Practice
|
May 20, 2022
Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis
Christopher S Strouse, Melissa C Larson, Shawna L Ehlers, et al.
British Journal of Haematology
|
June 28, 2017
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy
Umar Farooq, Matthew J Maurer, Carrie A Thompson, et al.
Bone Marrow Transplantation
|
April 11, 2006
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia
M A Elliott, A Tefferi, W J Hogan, et al.
Mayo Clinic Proceedings
|
February 13, 2004
Therapeutic options in patients with lymphoma and severe liver dysfunction
Irene M Ghobrial, Robert C Wolf, Denise L Pereira, et al.
American Journal of Hematology
|
December 6, 2018
Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018
Alessia Castellino, Jose S Pulido, Patrick B Johnston, et al.
Transplantation and Cellular Therapy
|
June 25, 2022
Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell Lymphoma
Aung M Tun, Seth Maliske, Yucai Wang, et al.
Transplantation and Cellular Therapy
|
July 12, 2024
Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy
Aung M Tun, Yucai Wang, Seth Maliske, et al.
Page
of 39